Local delivery of NO-donor molsidomine post-PTA improves haemodynamics, wall mechanics and histomorphometry in atherosclerotic porcine SFA

European Journal of Vascular and Endovascular Surgery

Volumn 23, Issue 3, 2002, Pages 226-233

  Rolland, P H ^a,d   Bartoli, J M ^a   Piquet, Ph ^a,b   Mekkaoui, C ^a   Nott, S H ^c   Moulin, G ^a   Amabile, P ^a,b   Mesana, T ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Atherosclerotic pigs; Local drug delivery; Molsidomine; NO donors; Post angioplasty restenosis

Indexed keywords

MOLSIDOMINE; NITRIC OXIDE DONOR; PLACEBO; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; CELL PROLIFERATION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMORAL ARTERY; HEMODYNAMICS; IMMUNOCYTOCHEMISTRY; MORPHOMETRICS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWINE; ANIMAL; ARTERIOSCLEROSIS; DRUG EFFECT; INTRADERMAL DRUG ADMINISTRATION; MALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE CARE; VASCULAR ENDOTHELIUM;

ADMINISTRATION, CUTANEOUS; ANGIOPLASTY, BALLOON; ANIMALS; ARTERIOSCLEROSIS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; HEMODYNAMIC PROCESSES; MALE; MOLSIDOMINE; NITRIC OXIDE DONORS; POSTOPERATIVE CARE; SWINE; VASODILATOR AGENTS;

EID: 0036514821     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1556     Document Type: Article

References (44)

1. GOLLEDGE J, FERGUSON K, ELLIS M et al. Outcome of femoropopliteal angioplasty. Ann Surg 1999; 229: 146-153.
2. JOHNSTON KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992; 183: 767-771.
3. KREPEL VM, VAN ANDEL GJ, VAN ERP WF, BRESLAU PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985; 156: 325-328.
4. SAPOVAL MR, LONG AL, RAYNAUD AC et al. Femoropopliteal stent placement: long-term results. Radiology 1992; 184: 833-839.
5. GLAGOV S. Intimal hyperplasia, vascular remodeling, and the restenosis problem. Circulation 1994; 2888-2891.
6. CHARPIOT P, BESCOND A, AUGIER T et al. Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. Matrix Biol 1998; 17: 559-574.
7. AUGIER T, CHARPIOT P, CHAREYRE C et al. Medial elastic structure alterations in atherosclerotic arteries in minipigs: plaque proximity and arterial site specificity. Matrix Biol 1997; 15: 455-467.
8. GEARY RL, ADAMS MR, BENJAMIN ME, WILLIAMS JK. Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys. J Am Coll Cardiol 1998; 31: 1158-1164.
9. MONDY JS, WILLIAMS JK, ADAMS MR, DEAN RH, GEARY RL. Structural determinants of lumen narrowing after angioplasty in atherosclerotic nonhuman primates. J Vasc Surg 1997; 26: 875-883.
10. FAXON DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol 1995; 25: 362-369.
11. IGNARRO LJ, LIPPTON H, EDWARDS JC et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
12. ROLLAND PH, SAMPOL J, LACARELLE B et al. Differential inhibitory effects of isosorbide dinitrate and its mononitrate metabolites on platelet aggregation and thromboxane formation. Pharmacol Res 1985; 2: 87-90.
13. BERENGER FP, CANO JP, ROLLAND PH. Antithrombogenic endothelial cell defense. Basal characteristics in cultured endothelial cells and modulation by short-term and long-term exposure to isosorbide nitrates. Circ Res 1987; 60: 612-620.
14. GARG UC, HASSID A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
15. SARKAR R, MEINBERG EG, STANLEY JC, GORDON D, WEBB RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996; 78: 225-230.
16. KOLPAKOV V, GORDON D, KULIK TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995; 76: 305-309.
17. WEVER RMF, LUSCHER TF, COSENTINO F, RABELINK TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108-112.
18. POLTE T, ABATE A, DENNERY PA, SCHRODER H. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 2000; 20: 1209-1215.
19. MESSIN R, KARPOV Y, BAIKOVA N et al. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina - a multicenter randomized double-blind crossover placebo-controlled trial. J Cardiovasc Pharm 1998; 31: 271-276.
20. ROSENKRANZ B, WINKELMANN BR, PARNHAM MJ. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet 1996; 30: 372-384.
21. BALDWIN AL, WILSON LM, GRADUS-PIZLO I, WILENSKY R, MARCH K. Effect of atherosclerosis on transmural convection an arterial ultrastructure. Implications for local intravascular drug delivery. Arterioscler Thromb Vasc Biol 1997; 17: 3365-3375.
22. BRIEGER D, TOPOL E. Local drug delivery systems and prevention of restenosis. Cardiovasc Res 1997; 35: 405-413.
23. HONG MK, BARRY JJ, LEON MB. Multichannel balloon catheter. Semin Interv Cardiol 1996; 1: 34-35.
24. HONG MK, WONG SC, FARB A et al. Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery. Cathet Cardiovasc Diagn 1995; 34: 263-270.
25. FROMSON JM, ILLING HP, INGS RM et al. Absorption and disposition of [14C]-molsidomine in laboratory animals. Arzneimittelforschung 1981; 31: 337-345.
26. ROLLAND PH, CHARIFI AB, JOURDHEUIL-RAHMANI D, PIQUET P, BARTOLI JM. Nitric oxyde-donor (Molsidomine) local delivery during angioplasty prevents restenosis due to smooth muscle cells but not adventitial contribution. Circulation 1997; 96: I-84-88.
27. LATRILLE V, GHIRINGHELLI O, JOURDHEUIL-RAHMANI D et al. Long-term treatment of atherosclerotic minipigs with isosorbide dinitrate restores nitric oxide release from endothelial cells, and inhibits vascular smooth muscle cell proliferation. Endothelium 1996; 4: 235-245.
28. ROLLAND PH, FRIGGI A, BARLATIER A et al. Hyper-homocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161-1174.
29. ROLLAND PH, CHARIFI AB, VERRIER C et al. Hemodynamics and wall mechanics after stent placement in swine iliac arteries: comparative results from six stent designs. Radiology 1999; 213: 229-246.
30. ROLLAND PH, CHARPIOT P, FRIGGI A et al. Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs. Am J Cardiol 1993; 71: 22E-27E.
31. LABLANCHE JM, GROLLIER G, LUSSON JR et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation 1997; 95: 83-89.
32. KALINOWSKI M, ALFKE H, BERGEN S et al. Comparative trial of local pharmacotherapy with L-arginine, r-Hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries. Radiology 2001; 219: 716-723.
33. GROVES PH, BANNING AP, PENNY WJ et al. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res 1995; 30: 87-96.
34. MEKKAOUI C, FRIGGI A, ROLLAND PH et al. Simultaneous measurements of arterial diameter and blood pressure to determine the arterial compliance, wall mechanics and stresses in vivo. Eur J Vasc Endovasc Surg 2001; 21: 208-213.
35. HOYER PF, SCHMID R, WUNSCH L, VESTER U. Color doppler energy - a new technique to study tissue perfusion in renal transplants. Pediatr Nephrol 1999; 13: 559-563.
36. GUDMUNDSSON S, VALENTIN L, PIRHONEN J et al. Factors affecting color doppler energy ultrasound recordings in an in-vitro model. Ultrasound Med Biol 1998; 24: 899-902.
37. DAVIES PF. Spatial hemodynamics, the endothelium, and focal atherogenesis: a cell cycle link? Circ Res 2000; 86: 114-116.
38. GIDDENS DP, ZARINS CK, GLAGOV S. The role of fluid mechanics in the localization and detection of atherosclerosis. J Biomech Eng 1993; 115: 588-594.
39. DREXLER H. Nitric oxide and coronary endothelial dysfunction in humans [review]. Cardiovasc Res 1999; 43: 572-579.
40. DELFINO A, STERGIOPULOS N, MOORE JE, MEISTER JJ. Residual strain effects on the stress field in a thick wall finite element model of the human carotid bifurcation. J Biomech 1997; 30: 777-786.
41. GREENWALD SE, MOORE JE, RACHEV A, KANE TP, MEISTER JJ. Experimental investigation of the distribution of residual strains in the artery wall. J Biomech Eng 1997; 119: 438-444.
42. BELZ GG. Elastic properties and Windkessel function of the human aorta. [Review] [87 refs]. Cardiovasc Drugs Ther 1995; 9: 73-83.
43. GIMBRONE MA, TOPPER JN, NAGEL T, ANDERSON KR, GARCIA-CARDENA G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 2000; 902: 230-239.
44. HIRONAKA K, YANO M, KOHNO M et al. In vivo aortic wall characteristics at the early stage of atherosclerosis in rabbits. Am J Physiol 1997; 273: H1142-H1147.